LifeMD (LFMD) News Today $7.36 -1.26 (-14.62%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Why Hims & Hers Health and LifeMD Are Skyrocketing TodayApril 29 at 3:19 PM | fool.comLifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay PatientsApril 29 at 8:05 AM | globenewswire.comMarshall Wace LLP Grows Holdings in LifeMD, Inc. (NASDAQ:LFMD)Marshall Wace LLP boosted its holdings in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 522.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 371,473 shares of the company's stock after acquirinApril 29 at 4:20 AM | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Receives $11.00 Consensus Price Target from AnalystsApril 29 at 1:37 AM | americanbankingnews.comLifeMD to Report First Quarter 2025 Financial Results on May 6April 28 at 4:16 PM | globenewswire.comLifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health MarketApril 28 at 8:00 AM | globenewswire.comLifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of "Buy" by AnalystsLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has been given a consensus recommendation of "Buy" by the six brokerages that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buApril 28 at 4:44 AM | marketbeat.comRenaissance Technologies LLC Acquires 158,796 Shares of LifeMD, Inc. (NASDAQ:LFMD)Renaissance Technologies LLC lifted its stake in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 45.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 510,000 shares of the company's stockApril 27 at 3:46 AM | marketbeat.comLifeMD expands acceptance of insurance to Medicare beneficiariesApril 17, 2025 | markets.businessinsider.comLifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss ProgramsApril 17, 2025 | globenewswire.comDynamic Technology Lab Private Ltd Raises Stake in LifeMD, Inc. (NASDAQ:LFMD)Dynamic Technology Lab Private Ltd lifted its position in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 134.2% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 100,836 shares of the company's stock after buying an additional 57,788 shares during tApril 11, 2025 | marketbeat.com95,557 Shares in LifeMD, Inc. (NASDAQ:LFMD) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. bought a new stake in LifeMD, Inc. (NASDAQ:LFMD - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 95,557 shares of the company's stock, valued at approximately $473,000. Raymond JaApril 10, 2025 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Short Interest UpdateLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 8,160,000 shares, a growth of 27.5% from the February 28th total of 6,400,000 shares. Currently, 23.6% of the shares of the stock are short sold. Based on an average daily volume of 1,150,000 shares, the days-to-cover ratio is currently 7.1 days.April 2, 2025 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Given Consensus Recommendation of "Buy" by BrokeragesShares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have been given a consensus rating of "Buy" by the seven research firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation, five have issued a buy recommendatioApril 2, 2025 | marketbeat.comLifeMD to Participate in the 24th Annual Needham Virtual Healthcare ConferenceMarch 31, 2025 | globenewswire.comLifeMD management to meet with TruistMarch 26, 2025 | markets.businessinsider.comLifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockMarch 25, 2025 | globenewswire.comRoyce & Associates LP Acquires 214,950 Shares of LifeMD, Inc. (NASDAQ:LFMD)Royce & Associates LP boosted its holdings in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 23.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,115,991 shares of the company's stock after purchasing an additional 214,950 shMarch 20, 2025 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Sees Significant Growth in Short InterestLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) saw a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 6,400,000 shares, a growth of 25.2% from the February 13th total of 5,110,000 shares. Based on an average trading volume of 1,060,000 shares, the days-to-cover ratio is currently 6.0 days. Currently, 18.8% of the shares of the company are sold short.March 18, 2025 | marketbeat.comInsider Selling: LifeMD, Inc. (NASDAQ:LFMD) CMO Sells 30,000 Shares of StockLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) CMO Jessica Friedeman sold 30,000 shares of the firm's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $5.66, for a total transaction of $169,800.00. Following the completion of the transaction, the chief marketing officer now directly owns 170,000 shares of the company's stock, valued at approximately $962,200. This trade represents a 15.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.March 18, 2025 | marketbeat.comJessica Friedeman Sells 30,000 Shares of LifeMD, Inc. (NASDAQ:LFMD) StockMarch 18, 2025 | insidertrades.comFirst Eagle Investment Management LLC Makes New Investment in LifeMD, Inc. (NASDAQ:LFMD)First Eagle Investment Management LLC acquired a new stake in LifeMD, Inc. (NASDAQ:LFMD - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 50,356 shares of the company's stock, valued at approximatelMarch 17, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Grows Stake in LifeMD, Inc. (NASDAQ:LFMD)Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 21.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 931,294 shares of the company's stock afteMarch 17, 2025 | marketbeat.comEquities Analysts Set Expectations for LifeMD Q1 EarningsLifeMD, Inc. (NASDAQ:LFMD - Free Report) - Analysts at B. Riley issued their Q1 2025 earnings estimates for shares of LifeMD in a research report issued on Tuesday, March 11th. B. Riley analyst A. Schock anticipates that the company will post earnings per share of ($0.07) for the quarter. B. RileMarch 15, 2025 | marketbeat.comB. Riley Upgrades LifeMD (NASDAQ:LFMD) to Strong-BuyB. Riley raised LifeMD to a "strong-buy" rating in a report on Tuesday.March 14, 2025 | marketbeat.comLifeMD (NASDAQ:LFMD) Price Target Raised to $14.00 at HC WainwrightHC Wainwright lifted their price target on LifeMD from $12.00 to $14.00 and gave the stock a "buy" rating in a research report on Wednesday.March 13, 2025 | marketbeat.comLifeMD's (LFMD) "Overweight" Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and set a $15.00 price target on shares of LifeMD in a research note on Tuesday.March 12, 2025 | marketbeat.comLifeMD (NASDAQ:LFMD) Announces Earnings Results, Beats Estimates By $0.02 EPSLifeMD (NASDAQ:LFMD - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.02.March 11, 2025 | marketbeat.comLake Street Keeps Their Buy Rating on LifeMD (LFMD)March 11, 2025 | markets.businessinsider.comLifeMD, Inc. (LFMD) Q4 2024 Earnings Call TranscriptMarch 10, 2025 | seekingalpha.comLifeMD Reports Fourth Quarter 2024 ResultsMarch 10, 2025 | globenewswire.comLifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Moderate Buy" from AnalystsLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating toMarch 7, 2025 | marketbeat.comTelehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer ZepboundMarch 6, 2025 | reuters.comLifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP ZepboundMarch 6, 2025 | globenewswire.comLifeMD to Participate in the KeyBanc Capital Markets Healthcare ForumMarch 5, 2025 | globenewswire.comLifeMD (LFMD) to Release Earnings on MondayLifeMD (NASDAQ:LFMD) will be releasing earnings after the market closes on Monday, March 10, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=669769)March 3, 2025 | marketbeat.comLifeMD to Report Fourth Quarter 2024 Financial Results on March 10February 25, 2025 | globenewswire.comLifeMD announces expansion into behavioral health marketFebruary 24, 2025 | markets.businessinsider.comLifeMD® Announces Entry Into the Behavioral Health MarketFebruary 24, 2025 | globenewswire.comLifeMD, Inc. (NASDAQ:LFMD) CEO Justin Schreiber Sells 50,000 SharesLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) CEO Justin Schreiber sold 50,000 shares of the business's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $7.55, for a total value of $377,500.00. Following the transaction, the chief executive officer now owns 2,653,715 shares of the company's stock, valued at approximately $20,035,548.25. This trade represents a 1.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.February 22, 2025 | marketbeat.comInsider Selling: LifeMD, Inc. (NASDAQ:LFMD) CEO Sells 50,000 Shares of StockFebruary 22, 2025 | insidertrades.comCraig-Hallum Sticks to Its Buy Rating for LifeMD (LFMD)February 14, 2025 | markets.businessinsider.comLifeMD, Inc. (NASDAQ:LFMD) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have received an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and six have issued a buy ratingFebruary 10, 2025 | marketbeat.comJPMorgan Chase & Co. Has $462,000 Position in LifeMD, Inc. (NASDAQ:LFMD)JPMorgan Chase & Co. boosted its holdings in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 496.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 88,173 shares of the company's stock after buyingJanuary 29, 2025 | marketbeat.comLifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceJanuary 28, 2025 | globenewswire.comMirador Capital Partners LP Grows Stake in LifeMD, Inc. (NASDAQ:LFMD)Mirador Capital Partners LP increased its stake in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 139.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 106,059 shares of the company's stock after purchasing an additional 61,73January 16, 2025 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of "Moderate Buy" by AnalystsShares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have earned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendation onJanuary 16, 2025 | marketbeat.comLifeMD (NASDAQ:LFMD) Given New $7.00 Price Target at KeyCorpKeyCorp cut their price objective on LifeMD from $10.00 to $7.00 and set an "overweight" rating on the stock in a research report on Wednesday.January 8, 2025 | marketbeat.comJustin Schreiber Sells 25,000 Shares of LifeMD, Inc. (NASDAQ:LFMD) StockJanuary 7, 2025 | insidertrades.comLifeMD, Inc. (NASDAQ:LFMD) CEO Sells $129,750.00 in StockLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) CEO Justin Schreiber sold 25,000 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $5.19, for a total transaction of $129,750.00. Following the sale, the chief executive officer now directly owns 2,703,715 shares in the company, valued at approximately $14,032,280.85. This represents a 0.92 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.January 6, 2025 | marketbeat.com Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address LFMD Media Mentions By Week LFMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFMD News Sentiment▼0.970.85▲Average Medical News Sentiment LFMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFMD Articles This Week▼122▲LFMD Articles Average Week Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CareDx News Today The Pennant Group News Today Aveanna Healthcare News Today Castle Biosciences News Today Fulgent Genetics News Today Fortrea News Today Auna News Today Talkspace News Today Celcuity News Today InnovAge News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFMD) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
